Human Organoids as Drug Development Tools for Polycystic Kidney Disease

Area of Science:

• Nephrology
• Stem Cell Biology
• Genetics

Background:

• Polycystic kidney disease (PKD) is a common inherited disorder caused by mutations in PC1 or PC2.
• Limited therapeutic options exist for PKD, partly due to a lack of effective in vitro models.
• Current research faces challenges in replicating PKD cystogenesis outside of animal models.

Purpose of the Study:

• To review the achievements and limitations of human kidney organoids in modeling PKD.
• To explore the potential of PKD organoids as drug development tools.
• To discuss future strategies for advancing PKD organoid technology.

Main Methods:

• Utilizing human pluripotent stem cells to generate kidney organoids from PKD1-/- or PKD2-/- cell lines.
• Characterizing the recapitulation of PKD-specific cystic phenotypes in vitro.
• Analyzing the cell-intrinsic nature of PKD cystogenesis.

Main Results:

• Human PKD organoids successfully replicate the characteristic cystic phenotype of PKD.
• The organoid system demonstrates that PKD cystogenesis is a cell-intrinsic process.
• PKD organoids have unveiled novel mechanisms underlying cyst formation and aided in designing therapeutic strategies.

Conclusions:

• Human kidney organoids represent a significant advancement for studying PKD in vitro.
• Despite current limitations in complexity and cost, PKD organoids hold great promise for drug discovery.
• Further technological development is crucial to enhance the physiological relevance and translational potential of PKD organoids.